Invention Grant
- Patent Title: Anaplerotic therapy of huntington disease and other polyglutamine diseases
-
Application No.: US15640018Application Date: 2017-06-30
-
Publication No.: US10220014B2Publication Date: 2019-03-05
- Inventor: Alexandra Durr , Fanny Mochel
- Applicant: INSERM (Institut National de la Sante et de la Recherche Medicale)
- Applicant Address: FR Paris
- Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale)
- Current Assignee: INSERM (Institut National de la Sante et de la Recherche Medicale)
- Current Assignee Address: FR Paris
- Agency: Cooley LLP
- Priority: EP06291873 20061204
- Main IPC: A61K31/225
- IPC: A61K31/225 ; A23L29/00 ; A23L33/115 ; A23L33/12
Abstract:
The present invention relates to a method for treating and/or preventing Huntington disease and other polyglutamine diseases, comprising the step of administering an effective amount of a precursor of propionyl-CoA to an individual in need thereof.
Public/Granted literature
- US20180021287A1 ANAPLEROTIC THERAPY OF HUNTINGTON DISEASE AND OTHER POLYGLUTAMINE DISEASES Public/Granted day:2018-01-25
Information query
